{"created":"2020-10-13T08:44:03.274474+00:00","id":5737,"links":{},"metadata":{"_buckets":{"deposit":"b684ef26-37a7-4f93-9b09-8cec9a196798"},"_deposit":{"created_by":37,"id":"5737","owner":"37","owners":[37],"owners_ext":{"displayname":"","email":"Papaaung99@gmail.com","username":""},"pid":{"revision_id":0,"type":"recid","value":"5737"},"status":"published"},"_oai":{"id":"oai:meral.edu.mm:recid/5737","sets":["1582963366982:1597649322614"]},"communities":["um1"],"item_1583103067471":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_1551255647225":"Outcome of Modification of Reintroduction Therapy in Patients with Anti-Tuberculosis Drug Induced Hepatotoxicity","subitem_1551255648112":"en"}]},"item_1583103085720":{"attribute_name":"Description","attribute_value_mlt":[{"interim":"Anti-tuberculosis drug induced hepatotoxicity (ATDH) is a significant problem in the developing countries as well\nas in Myanmar owing to high disease burden of tuberculosis, limited facilities for diagnosis and monitoring methods. This study aimed to find out the outcome of modification of reintroduced standard anti-TB drug regimen in patients with anti-TB drug induced hepatotoxicity. I"}]},"item_1583103108160":{"attribute_name":"Keywords","attribute_value_mlt":[{"interim":"ATDH"},{"interim":"Reintroduction"},{"interim":"Therapy"},{"interim":"Outcome"}]},"item_1583103120197":{"attribute_name":"Files","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2020-10-13"}],"displaytype":"preview","filename":"Outcome of modification of reintroduction therapy in patients with anti-tuberculosis drug induced.pdf","filesize":[{"value":"596 Kb"}],"format":"application/pdf","licensetype":"license_1","url":{"url":"https://meral.edu.mm/record/5737/files/Outcome of modification of reintroduction therapy in patients with anti-tuberculosis drug induced.pdf"},"version_id":"5d882bec-c193-4c1b-8ec7-09d12e69f9d5"}]},"item_1583103131163":{"attribute_name":"Journal articles","attribute_value_mlt":[{"subitem_issue":"1","subitem_journal_title":"Research Journal UM1","subitem_pages":"42-49","subitem_volume":"1"}]},"item_1583105942107":{"attribute_name":"Authors","attribute_value_mlt":[{"subitem_authors":[{"subitem_authors_fullname":"Khin Rupar Ko"},{"subitem_authors_fullname":"May Zabe"},{"subitem_authors_fullname":"Aye Mya Theingi Win"},{"subitem_authors_fullname":"Mya Paing"},{"subitem_authors_fullname":"Moe Moe San"}]}]},"item_1583108359239":{"attribute_name":"Upload type","attribute_value_mlt":[{"interim":"Publication"}]},"item_1583108428133":{"attribute_name":"Publication type","attribute_value_mlt":[{"interim":"Journal article"}]},"item_1583159729339":{"attribute_name":"Publication date","attribute_value":"2020-02-15"},"item_title":"Outcome of Modification of Reintroduction Therapy in Patients with Anti-Tuberculosis Drug Induced Hepatotoxicity","item_type_id":"21","owner":"37","path":["1597649322614"],"publish_date":"2020-10-13","publish_status":"0","recid":"5737","relation_version_is_last":true,"title":["Outcome of Modification of Reintroduction Therapy in Patients with Anti-Tuberculosis Drug Induced Hepatotoxicity"],"weko_creator_id":"37","weko_shared_id":-1},"updated":"2021-12-13T01:25:55.036804+00:00"}